United States Government Publishing Office publisher pbl distributor dst United States Congress House of Representatives author aut Government Organization text government publication eng BILLS To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.;FDA Reauthorization Act of 2017;Prescription Drug User Fee Amendments of 2017;Medical Device User Fee Amendments of 2017;Generic Drug User Fee Amendments of 2017;Biosimilar User Fee Amendments of 2017;H.R. 2430 (RH) Bills and Statutes 115_cong_bills legislative 2017-07-12 U.S. Government Publishing Office 2017-07-11 monographic deposited born digital 140 p. Y 1.6: Y 1.4/6: P0b002ee19582dd81 https://www.govinfo.gov/app/details/BILLS-115hr2430rh H.R. 2430 021-610-00252-9 000501532 000325573 Congressional bills House bills f:h2430_rh.txt https://www.govinfo.gov/app/details/BILLS-115hr2430rh https://www.govinfo.gov/content/pkg/BILLS-115hr2430rh/html/BILLS-115hr2430rh.htm https://www.govinfo.gov/content/pkg/BILLS-115hr2430rh/pdf/BILLS-115hr2430rh.pdf https://www.govinfo.gov/content/pkg/BILLS-115hr2430rh/xml/BILLS-115hr2430rh.xml fdlp DGPO 2017-07-12 2023-01-04 BILLS-115hr2430rh machine generated eng Greg Walden United States House of Representatives sponsor spn United States Congress Member Frank Pallone, Jr. United States House of Representatives cosponsor United States Congress Member Michael C. Burgess United States House of Representatives cosponsor United States Congress Member Gene Green United States House of Representatives cosponsor United States Congress Member United States Congress House of Representatives Committee on Energy and Commerce associated name asn Title 5 Section 552a Title 5 Section 552 5 U.S.C. 552a 5 U.S.C. 552 Title 21 Section 301(h) Title 21 Section 321 Title 21 Section 333 Title 21 Section 351et seq. Title 21 Section 355 Title 21 Section 355(j) Title 21 Section 355(j)(5) Title 21 Section 355(j)(5)(A) Title 21 Section 355(u)(4) Title 21 Section 355g(b) Title 21 Section 355g(d) Title 21 Section 356g(b)(1)(A) Title 21 Section 360bbb-5(f) Title 21 Section 360c Title 21 Section 360c(b) Title 21 Section 360c(b)(5)(D) Title 21 Section 360d Title 21 Section 360(h) Title 21 Section 360(m) Title 21 Section 360e-3 Title 21 Section 360e-3(f)(2) Title 21 Section 360e(c)(4)(A) Title 21 Section 360ee(c) Title 21 Section 360i Title 21 Section 360j Title 21 Section 360j(m)(6)(A)(iv) Title 21 Section 360m Title 21 Section 360n(a)(4) Title 21 Section 374 Title 21 Section 374(g) Title 21 Section 374(g)(11) Title 21 Section 379-42 Title 21 Section 379-42(g) Title 21 Section 379-42(h)(2) Title 21 Section 379-42(i) Title 21 Section 379g Title 21 Section 379h-2 Title 21 Section 379h Title 21 Section 379h(a) Title 21 Section 379h(d) Title 21 Section 379h(e) Title 21 Section 379h(f)(2) Title 21 Section 379h(g) Title 21 Section 379h(k) Title 21 Section 379i Title 21 Section 379iet seq. Title 21 Section 379j-12(a)(3) Title 21 Section 379j-1(a) Title 21 Section 379j-1(b) Title 21 Section 379j-41 Title 21 Section 379j-42(a) Title 21 Section 379j-42(b) Title 21 Section 379j-42(c) Title 21 Section 379j-42(d) Title 21 Section 379j-42(f) Title 21 Section 379j-43 Title 21 Section 379j-51(1) Title 21 Section 379j-51(3) Title 21 Section 379j-52 Title 21 Section 379j-52(a) Title 21 Section 379j-53 Title 21 Section 379j Title 21 Section 379j(a) Title 21 Section 379j(b) Title 21 Section 379j(c) Title 21 Section 379j(d) Title 21 Section 379j(e)(2)(C) Title 21 Section 379k-1(b) Title 21 Section 381(d) Title 21 Section 381(e)(4) Title 21 Section 384e(a)(1) Title 21 Section 739i Title 21 Section 739j-1 21 U.S.C. 301(h) 21 U.S.C. 321 21 U.S.C. 333 21 U.S.C. 351et seq. 21 U.S.C. 355 21 U.S.C. 355(j) 21 U.S.C. 355(j)(5) 21 U.S.C. 355(j)(5)(A) 21 U.S.C. 355(u)(4) 21 U.S.C. 355g(b) 21 U.S.C. 355g(d) 21 U.S.C. 356g(b)(1)(A) 21 U.S.C. 360bbb-5(f) 21 U.S.C. 360c 21 U.S.C. 360c(b) 21 U.S.C. 360c(b)(5)(D) 21 U.S.C. 360d 21 U.S.C. 360(h) 21 U.S.C. 360(m) 21 U.S.C. 360e-3 21 U.S.C. 360e-3(f)(2) 21 U.S.C. 360e(c)(4)(A) 21 U.S.C. 360ee(c) 21 U.S.C. 360i 21 U.S.C. 360j 21 U.S.C. 360j(m)(6)(A)(iv) 21 U.S.C. 360m 21 U.S.C. 360n(a)(4) 21 U.S.C. 374 21 U.S.C. 374(g) 21 U.S.C. 374(g)(11) 21 U.S.C. 379-42 21 U.S.C. 379-42(g) 21 U.S.C. 379-42(h)(2) 21 U.S.C. 379-42(i) 21 U.S.C. 379g 21 U.S.C. 379h-2 21 U.S.C. 379h 21 U.S.C. 379h(a) 21 U.S.C. 379h(d) 21 U.S.C. 379h(e) 21 U.S.C. 379h(f)(2) 21 U.S.C. 379h(g) 21 U.S.C. 379h(k) 21 U.S.C. 379i 21 U.S.C. 379iet seq. 21 U.S.C. 379j-12(a)(3) 21 U.S.C. 379j-1(a) 21 U.S.C. 379j-1(b) 21 U.S.C. 379j-41 21 U.S.C. 379j-42(a) 21 U.S.C. 379j-42(b) 21 U.S.C. 379j-42(c) 21 U.S.C. 379j-42(d) 21 U.S.C. 379j-42(f) 21 U.S.C. 379j-43 21 U.S.C. 379j-51(1) 21 U.S.C. 379j-51(3) 21 U.S.C. 379j-52 21 U.S.C. 379j-52(a) 21 U.S.C. 379j-53 21 U.S.C. 379j 21 U.S.C. 379j(a) 21 U.S.C. 379j(b) 21 U.S.C. 379j(c) 21 U.S.C. 379j(d) 21 U.S.C. 379j(e)(2)(C) 21 U.S.C. 379k-1(b) 21 U.S.C. 381(d) 21 U.S.C. 381(e)(4) 21 U.S.C. 384e(a)(1) 21 U.S.C. 739i 21 U.S.C. 739j-1 Title 42 Section 1320d-2note Title 42 Section 282note Title 42 Section 284m(e)(1) Title 42 Section 360j 42 U.S.C. 1320d-2note 42 U.S.C. 282note 42 U.S.C. 284m(e)(1) 42 U.S.C. 360j Public Law 110-85 Public Law 112-144 Public Law 114-255 H. Rept. 115-201 Union Calendar No. 138 hr BILLS-115hr2430rh 115 1 HOUSE HOUSE 2430 rh rh FDA Reauthorization Act of 2017 Prescription Drug User Fee Amendments of 2017 Medical Device User Fee Amendments of 2017 Generic Drug User Fee Amendments of 2017 Biosimilar User Fee Amendments of 2017 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes. Mr. Walden (for himself, Mr. Pallone, Mr. Burgess, and Mr. Gene Green of Texas) introduced the following bill; which was referred to the Committee on Energy and Commerce Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed Committee on Energy and Commerce Energy and Commerce Mr. Walden Greg Walden Walden, Greg Mr. Pallone Frank Pallone, Jr. Pallone, Frank, Jr. Frank Pallone Mr. Burgess Michael C. Burgess Burgess, Michael C. Mr. Michael Burgess Mr. Gene Green of Texas Gene Green Green, Gene false false